Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ASCO Annual Meeting 2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

2024 ASCO Annual Meeting

Keep up to date with all the top stories and latest evidence with our hub page, including official congress videos and expert takeaways.
ADVANCED SEARCH
Log in
Top
BMC Psychiatry
Published in: BMC Psychiatry 1/2020

01-12-2020 | Schizophrenia | Research article

Defining cognitive and functional profiles in schizophrenia and affective disorders

Authors: Yu-Chi Huang, Yu Lee, Chun-Yi Lee, Pao-Yen Lin, Chi-Fa Hung, Sheng-Yu Lee, Liang-Jen Wang

Published in: BMC Psychiatry | Issue 1/2020

Login to get access

Abstract

Background

Neurocognitive dysfunction is a common symptom of various major psychiatric disorders, including schizophrenia, major depressive disorder (MDD), and bipolar I disorder (BD). In this study, we investigated whether cognitive profiles and daily skill functioning could effectively differentiate between patients with schizophrenia, MDD, and BD.

Method

In this cross-sectional study, we recruited a total of 63 patients with schizophrenia, 55 patients with MDD, 43 patients with BD, and 92 healthy control subjects. We evaluated participants’ cognitive functions and functional capacity using the Brief Assessment of Cognition in Schizophrenia (BACS) and the UCSD Performance-based Skills Assessment, Brief Version (UPSA-B), respectively. Multivariate analysis of covariance was then adopted to determine inter-group differences in BACS and UPSA-B performance.

Results

The BACS was capable of differentiating patients with a major psychiatric disorder (schizophrenia, MDD, and BD) from healthy subjects. Furthermore, schizophrenia patients had poorer motor speed performance than patients with affective disorders. The UPSA-B, particularly the financial portion, was able to distinguish schizophrenia patients from other groups. However, we did not observe any differences in UPSA-B performance between patients with mood disorders and the healthy controls. No significant difference between patients with BD and those with MDD were observed in either cognitive function or in functional capacity. The performances of the BACS and the UPSA-B were positively correlated, particularly in the MDD group.

Conclusion

Considering overall performance, the BACS and the UPSA-B characterize different endophenotyping profiles in the aforementioned four participant groups. Therefore, the results support the need for comprehensive assessments that target both cognitive function and functional capacity for patients with major psychiatric disorders.
Appendix
Available only for authorised users
Literature
1.
Harvey PD, Bowie CR, Friedman JI. Cognition in schizophrenia. Curr Psychiatry Rep. 2001;3(5):423–8.PubMedCrossRef
2.
Bourne C, Aydemir O, Balanza-Martinez V, Bora E, Brissos S, Cavanagh JT, Clark L, Cubukcuoglu Z, Dias VV, Dittmann S, et al. Neuropsychological testing of cognitive impairment in euthymic bipolar disorder: an individual patient data meta-analysis. Acta Psychiatr Scand. 2013;128(3):149–62.PubMedCrossRef
3.
Rock PL, Roiser JP, Riedel WJ, Blackwell AD. Cognitive impairment in depression: a systematic review and meta-analysis. Psychol Med. 2014;44(10):2029–40.PubMedCrossRef
4.
Kitchen H, Rofail D, Heron L, Sacco P. Cognitive impairment associated with schizophrenia: a review of the humanistic burden. Adv Ther. 2012;29(2):148–62.PubMedCrossRef
5.
Bortolato B, Miskowiak KW, Kohler CA, Vieta E, Carvalho AF. Cognitive dysfunction in bipolar disorder and schizophrenia: a systematic review of meta-analyses. Neuropsychiatr Dis Treat. 2015;11:3111–25.PubMedPubMedCentral
6.
Daniel BD, Montali A, Gerra ML, Innamorati M, Girardi P, Pompili M, Amore M. Cognitive impairment and its associations with the path of illness in affective disorders: a comparison between patients with bipolar and unipolar depression in remission. J Psychiatr Pract. 2013;19(4):275–87.PubMedCrossRef
7.
Xu G, Lin K, Rao D, Dang Y, Ouyang H, Guo Y, Ma J, Chen J. Neuropsychological performance in bipolar I, bipolar II and unipolar depression patients: a longitudinal, naturalistic study. J Affect Disord. 2012;136(3):328–39.PubMedCrossRef
8.
Hochberger WC, Combs T, Reilly JL, Bishop JR, Keefe RSE, Clementz BA, Keshavan MS, Pearlson GD, Tamminga CA, Hill SK, et al. Deviation from expected cognitive ability across psychotic disorders. Schizophr Res. 2018;192:300–7.PubMedCrossRef
9.
Hill SK, Reilly JL, Keefe RS, Gold JM, Bishop JR, Gershon ES, Tamminga CA, Pearlson GD, Keshavan MS, Sweeney JA. Neuropsychological impairments in schizophrenia and psychotic bipolar disorder: findings from the bipolar-schizophrenia network on intermediate phenotypes (B-SNIP) study. Am J Psychiatry. 2013;170(11):1275–84.PubMedPubMedCentralCrossRef
10.
Snitz BE, Macdonald AW 3rd, Carter CS. Cognitive deficits in unaffected first-degree relatives of schizophrenia patients: a meta-analytic review of putative endophenotypes. Schizophr Bull. 2006;32(1):179–94.PubMedPubMedCentralCrossRef
11.
Dikeos DG, Wickham H, McDonald C, Walshe M, Sigmundsson T, Bramon E, Grech A, Toulopoulou T, Murray R, Sham PC. Distribution of symptom dimensions across Kraepelinian divisions. Br J Psychiatry. 2006;189:346–53.PubMedCrossRef
12.
Hafner H, Maurer K, Trendler G, an der Heiden W, Schmidt M. The early course of schizophrenia and depression*. Eur Arch Psychiatry Clin Neurosci. 2005;255(3):167–73.PubMedCrossRef
13.
Barch DM, Ceaser A. Cognition in schizophrenia: core psychological and neural mechanisms. Trends Cogn Sci. 2012;16(1):27–34.PubMedCrossRef
14.
Hoe M, Nakagami E, Green MF, Brekke JS. The causal relationships between neurocognition, social cognition and functional outcome over time in schizophrenia: a latent difference score approach. Psychol Med. 2012;42(11):2287–99.PubMedCrossRef
15.
Su CC, Bai YM, Chou MH, Wang JD, Yang YK. Estimate dynamic changes of dysfunction and lifelong spent for psychiatric care needs in patients with schizophrenia. Eur Psychiatry. 2018;54:65–70.PubMedCrossRef
16.
Kern RS, Green MF, Nuechterlein KH, Deng BH. NIMH-MATRICS survey on assessment of neurocognition in schizophrenia. Schizophr Res. 2004;72(1):11–9.PubMedCrossRef
17.
Keefe RS, Goldberg TE, Harvey PD, Gold JM, Poe MP, Coughenour L. The brief assessment of cognition in schizophrenia: reliability, sensitivity, and comparison with a standard neurocognitive battery. Schizophr Res. 2004;68(2–3):283–97.PubMedCrossRef
18.
Keefe RS, Poe M, Walker TM, Harvey PD. The relationship of the brief assessment of cognition in schizophrenia (BACS) to functional capacity and real-world functional outcome. J Clin Exp Neuropsychol. 2006;28(2):260–9.PubMedCrossRef
19.
Keefe RS, Poe M, Walker TM, Kang JW, Harvey PD. The schizophrenia cognition rating scale: an interview-based assessment and its relationship to cognition, real-world functioning, and functional capacity. Am J Psychiatry. 2006;163(3):426–32.PubMedCrossRef
20.
Keefe RS, Harvey PD, Goldberg TE, Gold JM, Walker TM, Kennel C, Hawkins K. Norms and standardization of the brief assessment of cognition in schizophrenia (BACS). Schizophr Res. 2008;102(1–3):108–15.PubMedCrossRef
21.
Wang LJ, Lin PY, Lee Y, Huang YC, Hsu ST, Hung CF, Chen CK, Chen YC, Wang YL, Tsai MC. Validation of the Chinese version of brief assessment of cognition in schizophrenia. Neuropsychiatr Dis Treat. 2016;12:2819–26.PubMedPubMedCentralCrossRef
22.
Cholet J, Sauvaget A, Vanelle JM, Hommet C, Mondon K, Mamet JP, Camus V. Using the brief assessment of cognition in schizophrenia (BACS) to assess cognitive impairment in older patients with schizophrenia and bipolar disorder. Bipolar Disord. 2014;16(3):326–36.PubMedCrossRef
23.
Terachi S, Yamada T, Pu S, Yokoyama K, Matsumura H, Kaneko K. Comparison of neurocognitive function in major depressive disorder, bipolar disorder, and schizophrenia in later life: a cross-sectional study of euthymic or remitted, non-demented patients using the Japanese version of the brief assessment of cognition in schizophrenia (BACS-J). Psychiatry Res. 2017;254:205–10.PubMedCrossRef
24.
Chen CK, Lee CY, Lee Y, Hung CF, Huang YC, Lee SY, Huang MC, Chong MY, Chen YC, Wang LJ. Could schizoaffective disorder, schizophrenia and bipolar I disorder be distinguishable using cognitive profiles? Psychiatry Res. 2018;266:79–84.PubMedCrossRef
25.
Schmidt SJ, Mueller DR, Roder V. Social cognition as a mediator variable between neurocognition and functional outcome in schizophrenia: empirical review and new results by structural equation modeling. Schizophr Bull. 2011;37(Suppl 2):S41–54.PubMedPubMedCentralCrossRef
26.
Harvey PD, Velligan DI, Bellack AS. Performance-based measures of functional skills: usefulness in clinical treatment studies. Schizophr Bull. 2007;33(5):1138–48.PubMedPubMedCentralCrossRef
27.
Becattini-Oliveira AC, Dutra DF, Spenciere de Oliveira Campos B, de Araujo VC, Charchat-Fichman H. A systematic review of a functional assessment tool: UCSD performance-based skill assessment (UPSA). Psychiatry Res. 2018;267:12–8.PubMedCrossRef
28.
Patterson TL, Goldman S, McKibbin CL, Hughs T, Jeste DV. UCSD performance-based skills assessment: development of a new measure of everyday functioning for severely mentally ill adults. Schizophr Bull. 2001;27(2):235–45.PubMedCrossRef
29.
Mausbach BT, Bowie CR, Harvey PD, Twamley EW, Goldman SR, Jeste DV, Patterson TL. Usefulness of the UCSD performance-based skills assessment (UPSA) for predicting residential independence in patients with chronic schizophrenia. J Psychiatr Res. 2008;42(4):320–7.PubMedCrossRef
30.
Narayanan SS, Bhatia T, Velligan DI, Nimgaonkar VL, Deshpande SN. A case control study of association between cognition and functional capacity in schizophrenia. Schizophr Res. 2015;169(1–3):165–8.PubMedPubMedCentralCrossRef
31.
Mausbach BT, Harvey PD, Pulver AE, Depp CA, Wolyniec PS, Thornquist MH, Luke JR, McGrath JA, Bowie CR, Patterson TL. Relationship of the brief UCSD performance-based skills assessment (UPSA-B) to multiple indicators of functioning in people with schizophrenia and bipolar disorder. Bipolar Disord. 2010;12(1):45–55.PubMedPubMedCentralCrossRef
32.
Mahmood Z, Burton CZ, Vella L, Twamley EW. Neuropsychological predictors of performance-based measures of functional capacity and social skills in individuals with severe mental illness. J Psychiatr Res. 2018;102:201–6.PubMedPubMedCentralCrossRef
33.
McIntosh BJ, Zhang XY, Kosten T, Tan SP, Xiu MH, Rakofsky J, Harvey PD. Performance-based assessment of functional skills in severe mental illness: results of a large-scale study in China. J Psychiatr Res. 2011;45(8):1089–94.PubMedPubMedCentralCrossRef
34.
American Psychiatric Association. Diagnostic and statistical manual of mental disorders. Washington, DC: American Psychiatric Association; 2000.
35.
Leucht S, Kane JM, Kissling W, Hamann J, Etschel E, Engel RR. What does the PANSS mean? Schizophr Res. 2005;79(2–3):231–8.PubMedCrossRef
36.
Zimmerman M, Martinez JH, Young D, Chelminski I, Dalrymple K. Severity classification on the Hamilton depression rating scale. J Affect Disord. 2013;150(2):384–8.PubMedCrossRef
37.
38.
Hochberger WC, Hill SK, Nelson CL, Reilly JL, Keefe RS, Pearlson GD, Keshavan MS, Tamminga CA, Clementz BA, Sweeney JA. Unitary construct of generalized cognitive ability underlying BACS performance across psychotic disorders and in their first-degree relatives. Schizophr Res. 2016;170(1):156–61.PubMedCrossRef
39.
Wang LJ, Huang YC, Hung CF, Chen CK, Chen YC, Lee PY, Wang SM, Liu MH, Lin CJ, Hsu ST. The Chinese version of the brief assessment of cognition in schizophrenia: data of a large-scale mandarin-speaking population. Arch Clin Neuropsychol. 2017;32(3):289–96.PubMedCrossRef
40.
Mausbach BT, Harvey PD, Goldman SR, Jeste DV, Patterson TL. Development of a brief scale of everyday functioning in persons with serious mental illness. Schizophr Bull. 2007;33(6):1364–72.PubMedPubMedCentralCrossRef
41.
Kay SR, Fiszbein A, Opler LA. The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr Bull. 1987;13(2):261–76.PubMedCrossRef
42.
Sawamura J, Morishita S, Ishigooka J. Is there a linear relationship between the brief psychiatric rating scale and the clinical global impression-schizophrenia scale? A retrospective analysis. BMC Psychiatry. 2010;10:105.PubMedPubMedCentralCrossRef
43.
Ramos-Brieva JA, Cordero-Villafafila A. A new validation of the Hamilton rating scale for depression. J Psychiatr Res. 1988;22(1):21–8.PubMedCrossRef
44.
Zheng YP, Zhao JP, Phillips M, Liu JB, Cai MF, Sun SQ, Huang MF. Validity and reliability of the Chinese Hamilton depression rating scale. Br J Psychiatry. 1988;152:660–4.PubMedCrossRef
45.
Young RC, Biggs JT, Ziegler VE, Meyer DA. A rating scale for mania: reliability, validity and sensitivity. Br J Psychiatry. 1978;133:429–35.PubMedCrossRef
46.
Sellin AK, Shad M, Tamminga C. Muscarinic agonists for the treatment of cognition in schizophrenia. CNS Spectr. 2008;13(11):985–96.PubMedCrossRef
47.
Aringhieri S, Carli M, Kolachalam S, Verdesca V, Cini E, Rossi M, McCormick PJ, Corsini GU, Maggio R, Scarselli M. Molecular targets of atypical antipsychotics: from mechanism of action to clinical differences. Pharmacol Ther. 2018;192:20–41.PubMedCrossRef
48.
Barch DM. Neuropsychological abnormalities in schizophrenia and major mood disorders: similarities and differences. Curr Psychiatry Rep. 2009;11(4):313–9.PubMedPubMedCentralCrossRef
49.
Ancin I, Cabranes JA, Santos JL, Sanchez-Morla E, Barabash A. Executive deficits: a continuum schizophrenia-bipolar disorder or specific to schizophrenia? J Psychiatr Res. 2013;47(11):1564–71.PubMedCrossRef
50.
Lee CY, Wang LJ, Lee Y, Hung CF, Huang YC, Lee MI, Lee SY. Differentiating bipolar disorders from unipolar depression by applying the brief assessment of cognition in affective disorders. Psychol Med. 2018;48(6):929–38.PubMedCrossRef
51.
Varga M, Magnusson A, Flekkoy K, David AS, Opjordsmoen S. Clinical and neuropsychological correlates of insight in schizophrenia and bipolar I disorder: does diagnosis matter? Compr Psychiatry. 2007;48(6):583–91.PubMedCrossRef
52.
Seidman LJ, Kremen WS, Koren D, Faraone SV, Goldstein JM, Tsuang MT. A comparative profile analysis of neuropsychological functioning in patients with schizophrenia and bipolar psychoses. Schizophr Res. 2002;53(1–2):31–44.PubMedCrossRef
53.
Cuesta MJ, Peralta V. Cognitive disorders in the positive, negative, and disorganization syndromes of schizophrenia. Psychiatry Res. 1995;58(3):227–35.PubMedCrossRef
54.
Nielsen RE, Levander S, Kjaersdam Telleus G, Jensen SO, Ostergaard Christensen T, Leucht S. Second-generation antipsychotic effect on cognition in patients with schizophrenia--a meta-analysis of randomized clinical trials. Acta Psychiatr Scand. 2015;131(3):185–96.PubMedCrossRef
55.
Kawai N, Yamakawa Y, Baba A, Nemoto K, Tachikawa H, Hori T, Asada T, Iidaka T. High-dose of multiple antipsychotics and cognitive function in schizophrenia: the effect of dose-reduction. Prog Neuro-Psychopharmacol Biol Psychiatry. 2006;30(6):1009–14.CrossRef
56.
Kontis D, Theochari E, Kleisas S, Kalogerakou S, Andreopoulou A, Psaras R, Makris Y, Karouzos C, Tsaltas E. Doubtful association of antipsychotic polypharmacy and high dosage with cognition in chronic schizophrenia. Prog Neuro-Psychopharmacol Biol Psychiatry. 2010;34(7):1333–41.CrossRef
57.
Barnett JH, Croudace TJ, Jaycock S, Blackwell C, Hynes F, Sahakian BJ, Joyce EM, Jones PB. Improvement and decline of cognitive function in schizophrenia over one year: a longitudinal investigation using latent growth modelling. BMC Psychiatry. 2007;7:16.PubMedPubMedCentralCrossRef
58.
Christensen MC, Sluth LB, McIntyre RS. Validation of the University of California san Diego Performance-based skills assessment (UPSA) in major depressive disorder: replication and extension of initial findings. J Affect Disord. 2018;245:508–16.PubMedCrossRef
59.
Kotov R, Fochtmann L, Li K, Tanenberg-Karant M, Constantino EA, Rubinstein J, Perlman G, Velthorst E, Fett AJ, Carlson G, et al. Declining clinical course of psychotic disorders over the two decades following first hospitalization: evidence from the Suffolk County mental health project. Am J Psychiatry. 2017;174(11):1064–74.PubMedPubMedCentralCrossRef
60.
Yang Z, Abdul Rashid NA, Quek YF, Lam M, See YM, Maniam Y, Dauwels J, Tan BL, Lee J. Montreal cognitive assessment as a screening instrument for cognitive impairments in schizophrenia. Schizophr Res. 2018;199:58–63.PubMedCrossRef
61.
Sumiyoshi T, Nishida K, Niimura H, Toyomaki A, Morimoto T, Tani M, Inada K, Ninomiya T, Hori H, Manabe J, et al. Cognitive insight and functional outcome in schizophrenia; a multi-center collaborative study with the specific level of functioning scale-Japanese version. Schizophr Res Cogn. 2016;6:9–14.PubMedPubMedCentralCrossRef
Metadata
Title
Defining cognitive and functional profiles in schizophrenia and affective disorders
Authors
Yu-Chi Huang
Yu Lee
Chun-Yi Lee
Pao-Yen Lin
Chi-Fa Hung
Sheng-Yu Lee
Liang-Jen Wang
Publication date
01-12-2020
Publisher
BioMed Central
Published in
BMC Psychiatry / Issue 1/2020
Electronic ISSN: 1471-244X
DOI
https://doi.org/10.1186/s12888-020-2459-y

Other articles of this Issue 1/2020

BMC Psychiatry 1/2020 Go to the issue

Case report

Late-onset attention-deficit/hyperactivity disorder as a differential diagnosis of dementia: a case report

Research article

The use of long-acting Aripiprazole in a multi-center, prospective, uncontrolled, open-label, cohort study in Germany: a report on global assessment of functioning and the WHO wellbeing index

Research article

Females with ADHD: An expert consensus statement taking a lifespan approach providing guidance for the identification and treatment of attention-deficit/ hyperactivity disorder in girls and women

Case report

Bipolar disorder in megalencephalic leukoencephalopathy with subcortical cysts: a case report

Research article

Validation of the Finnish Health Improvement Profile (HIP) with patients with severe mental illness

Research article

Validation of the French version of the McLean screening instrument for borderline personality disorder (MSI-BPD) in an adolescent sample